Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. AlloVir Inc shares valued at $304 were sold by Hagen Brett R on Nov 19 ’24. At $0.55 per share, Hagen Brett R sold 554 shares. The insider’s holdings dropped to 68,506 shares worth approximately $39048.42 following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Sinha Vikas sold 3,186 shares, netting a total of over 1,748 in proceeds. Following the sale of shares at $0.55 each, the insider now holds 1,140,894 shares.
Before that, Miller Edward had sold 432 shares from its account. In a trade valued at $237, the General Counsel traded AlloVir Inc shares for $0.55 each. Upon closing the transaction, the insider’s holdings decreased to 432 shares, worth approximately $0.12 million.
As published in a research note from BofA Securities on December 26, 2023, AlloVir Inc [ALVR] has been rated down from a Buy to an Underperform and the price target has been revised to $1 from $17. Analysts at Piper Sandler downgraded the stock from ‘”an Overweight”‘ to ‘”a Neutral”‘ outlook in a report released in late December. As of December 22, 2023, Leerink Partners has decreased its “an Outperform” rating to a “Market perform” for ALVR. Earlier on December 22, 2023, JP Morgan downgraded its rating. Their new recommendation was “an Underweight” for ALVR stock which previously was a “an Overweight”.
Analyzing ALVR Stock Performance
During the last five days, there has been a surge of approximately 1.19%. Over the course of the year, AlloVir Inc shares have dropped approximately -16.14%. Shares of the company reached a 52-week high of $1.0500 on 11/04/24 and a 52-week low of $0.5153 on 11/19/24. A 50-day SMA is recorded $0.7779, while a 200-day SMA reached $0.7600. Nevertheless, trading volume fell to 0.65 million shares from 0.22 million shares the previous day.
Support And Resistance Levels for AlloVir Inc (ALVR)
According to the 24-hour chart, there is a support level at 0.5414, which, if violated, would cause prices to drop to 0.5127. In the upper region, resistance lies at 0.6174. The next price resistance is at 0.6647. RSI (Relative Strength Index) is 37.65 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.1530, which suggests the price will decrease in the coming days. Percent R is at 89.75%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
